Lage H - Search Results

1

Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.

Györffy B, Serra V, Materna V, Schäfer R, Dietel M, Schadendorf D, Lage H. Györffy B, et al. Among authors: lage h. Melanoma Res. 2006 Apr;16(2):147-55. doi: 10.1097/01.cmr.0000215037.23188.58. Melanoma Res. 2006. PMID: 16567970

2

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells.

Lage H, Dietel M. Lage H, et al. J Cancer Res Clin Oncol. 2002 Jul;128(7):349-57. doi: 10.1007/s00432-002-0349-y. Epub 2002 Jun 26. J Cancer Res Clin Oncol. 2002. PMID: 12136248

3

Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells.

Ludwig A, Dietel M, Lage H. Ludwig A, et al. Among authors: lage h. Anticancer Res. 2002 Nov-Dec;22(6A):3213-21. Anticancer Res. 2002. PMID: 12530067

4

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.

Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R. Györffy B, et al. Among authors: lage h. Oncogene. 2005 Nov 17;24(51):7542-51. doi: 10.1038/sj.onc.1208908. Oncogene. 2005. PMID: 16044152

5

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Györffy B, Surowiak P, Kiesslich O, Denkert C, Schäfer R, Dietel M, Lage H. Györffy B, et al. Among authors: lage h. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570. Int J Cancer. 2006. PMID: 16217747

6

A Web-based data warehouse on gene expression in human malignant melanoma.

Györffy B, Lage H. Györffy B, et al. Among authors: lage h. J Invest Dermatol. 2007 Feb;127(2):394-9. doi: 10.1038/sj.jid.5700543. Epub 2006 Aug 31. J Invest Dermatol. 2007. PMID: 16946712 Free article.

7

RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.

Materna V, Pleger J, Hoffmann U, Lage H. Materna V, et al. Among authors: lage h. Gynecol Oncol. 2004 Jul;94(1):152-60. doi: 10.1016/j.ygyno.2004.03.035. Gynecol Oncol. 2004. PMID: 15262134

8

Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.

Materna V, Liedert B, Thomale J, Lage H. Materna V, et al. Among authors: lage h. Int J Cancer. 2005 Jun 20;115(3):393-402. doi: 10.1002/ijc.20899. Int J Cancer. 2005. PMID: 15688364

9

Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates.

Surowiak P, Materna V, Drag-Zalesinska M, Wojnar A, Kaplenko I, Spaczyński M, Dietel M, Zabel M, Lage H. Surowiak P, et al. Among authors: lage h. Int J Gynecol Pathol. 2006 Apr;25(2):131-9. doi: 10.1097/01.pgp.0000183050.30212.2f. Int J Gynecol Pathol. 2006. PMID: 16633061

10

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.

Materna V, Stege A, Surowiak P, Priebsch A, Lage H. Materna V, et al. Among authors: lage h. Biochem Biophys Res Commun. 2006 Sep 15;348(1):153-7. doi: 10.1016/j.bbrc.2006.07.022. Epub 2006 Jul 14. Biochem Biophys Res Commun. 2006. PMID: 16876126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters